Evermay Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-22
Closed -$1.51K 603
2024
Q2
$1.51K Hold
22
﹤0.01% 555
2024
Q1
$1.18K Hold
22
﹤0.01% 563
2023
Q4
$1.17K Hold
22
﹤0.01% 542
2023
Q3
$1.09K Hold
22
﹤0.01% 524
2023
Q2
$1.31K Hold
22
﹤0.01% 515
2023
Q1
$1.25K Hold
22
﹤0.01% 497
2022
Q4
$1.63K Hold
22
﹤0.01% 499
2022
Q3
$1K Buy
+22
New +$1.32K ﹤0.01% 495

Other funds holding GMED

Evermay Wealth Management's GMED Position: Q3 2024 in Review

Evermay Wealth Management sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 22 shares — an estimated $1.51K sold.

Evermay Wealth Management first reported a position in GMED in Q3 2022 and held it in 8 quarters. The position peaked at $1.63K in Q4 2022. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Evermay Wealth Management reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
  • Evermay Wealth Management sold 22 Globus Medical shares in Q3 2024, an estimated $1.51K.
  • Evermay Wealth Management first reported a position in Globus Medical in Q3 2022 and held it in 8 quarters.
  • Evermay Wealth Management's Globus Medical position peaked at $1.63K in Q4 2022.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Evermay Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.